Page Image

GI Oncology Now

The leading medical news resource for practicing oncologists and health care providers treating gastrointestinal malignancies

Bile Duct Cancer
Evaluating Plasma Uracil Concentration in Patients Without DPD Deficiency

Gabriel Brooks, MD, of the Dartmouth Cancer Center, discusses the use of plasma uracil concentration as a screening test for DPD deficiency in patients with gastrointestinal cancer.

Dr. Brooks also explains the association between male sex and 5-FU exposure as well as the study's overall findings regarding toxicity and DPYD genotype in patients without known DPD deficiency.

Advertisement

Latest News

Advertisement

Conference Coverage

Expert Interviews

Knowledge Hubs

Colorectal Cancer
Advertisement
Advertisement